BusinessWire
Ladenburg Thalmann Expands Investment Banking Platform with Biotechnology Specialist Dr. Aydin Huseynov, M.D., CFANEW YORK–(BUSINESS WIRE)–Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann”), a leading middle-market investment bank providing investment banking, equity research, and… Read more »
Veradermics Announces Launch of Public OfferingNEW HAVEN, Conn.–(BUSINESS WIRE)–Veradermics, Incorporated (“Veradermics”) (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for… Read more »
Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions ConferenceNEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will present at the Bernstein’s 42nd Annual Strategic Decisions Conference on Wednesday,… Read more »
Eight Student Teams Named National Winners of 34th Annual ExploraVision CompetitionMCLEAN, Va.–(BUSINESS WIRE)– #ExploraVision–Toshiba and the National Science Teaching Association (NSTA) today announce eight national winners of the 34th annual… Read more »
Travere Therapeutics to Report First Quarter 2026 Financial ResultsSAN DIEGO–(BUSINESS WIRE)–Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report first quarter 2026 financial results on Monday, May… Read more ».jpg)
Dyno Therapeutics to Present New Capsids and AI Advancements in Gene Delivery at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual MeetingWATERTOWN, Mass.–(BUSINESS WIRE)–Dyno Therapeutics to present new capsids and AI advancements in gene delivery at the 29th American Society of… Read more »
Strand Therapeutics to Present Preclinical Data on Its Programmable mRNA In Vivo CAR-T Platform at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual MeetingBOSTON–(BUSINESS WIRE)–Strand Therapeutics to present preclinical data on its programmable mRNA in vivo CAR-T platform at the ASGCT 2026 Annual… Read more »
AviadoBio Announces Agreement with Apertura Gene Therapy to License TfR1 CapX™, a Next-Generation Blood-Brain Barrier-Crossing CapsidLONDON & NEW YORK–(BUSINESS WIRE)–AviadoBio Ltd. (“AviadoBio”) and Apertura Gene Therapy (“Apertura”), a biotechnology company developing next-generation AAV capsids for… Read more »
Sail Biomedicines to Present Preclinical Data Supporting Advancement of Its In Vivo eRNA™ CAR-T Product Candidate to the Clinic at ASGCT 2026 and TIDES USA 2026CAMBRIDGE, Mass.–(BUSINESS WIRE)– #ASGCT26–Sail to Present Preclinical Data Supporting Advancement of Its In Vivo eRNA™ CAR-T Product Candidate to the… Read more »
Mirai Bio to Unveil Two Next Generation Programs for Targeted Nucleic Acid Delivery Beyond the Liver at ASGCT 2026CAMBRIDGE, Mass.–(BUSINESS WIRE)– #ASGCT26–Mirai Bio to Unveil Two Next Generation Programs for Targeted Nucleic Acid Delivery Beyond the Liver at… Read more »
Encoded Therapeutics to Present ETX101 Data in Dravet Syndrome at the 2026 ASGCT Presidential SymposiumSOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #ASGCT2026–Encoded Therapeutics Inc., a clinical-stage genetic medicines company, today announced its participation in the 29th… Read more ».jpg)
Tr1X to Present New Clinical and Preclinical Data on Engineered Tr1 Treg Cell Therapies at ASGCT 2026SAN DIEGO–(BUSINESS WIRE)– #ASGCT26–Tr1X to Present New Clinical and Preclinical Data on Engineered Tr1 Treg Cell Therapies at ASGCT 2026 Read more »
Dispatch Bio Presents SEND T Cell Armoring Strategy at ASGCT 2026 Annual MeetingPHILADELPHIA & SAN FRANCISCO–(BUSINESS WIRE)–Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare… Read more »
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlookVENLO, the Netherlands–(BUSINESS WIRE)—- $QGEN #QIAGEN–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary results for the first… Read more »
Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with CardiomyopathyDUBLIN–(BUSINESS WIRE)—- $PRTA #Prothena–Prothena announces Novo Nordisk obtains Fast Track Designation from the U.S. FDA for coramitug (PRX004) in ATTR… Read more »
Janux Therapeutics Announces Discontinuation of JANX008 Clinical DevelopmentSAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics, Inc. (Nasdaq: JANX) (“Janux”), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today… Read more ».jpg)
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026SAN DIEGO–(BUSINESS WIRE)—- $ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on… Read more »
Eurofins Scientific: Director/PDMR ShareholdingLUXEMBOURG–(BUSINESS WIRE)–Regulatory News: Eurofins Scientific SE (Paris:ERF) (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”).… Read more »
Netsmart Showcases Proven Impact of Meaningful AI for Community-Based Care Providers at NatCon26OVERLAND PARK, Kan.–(BUSINESS WIRE)– #ArtificialIntelligence–Netsmart, an industry-leading technology platform company with a suite of solutions and services for community-based providers,… Read more »
Taiwan's Representative to the United States Alexander Tah-ray Yui Visits PharmaEssentia's Puerto Rico Facility Alongside Puerto Rico OfficialsBURLINGTON, Mass.–(BUSINESS WIRE)–PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical company headquartered in Taiwan, announced that Taiwan’s Representative to the United… Read more »
VGM & Trace Medical Announce New Exclusive Agreement Expanding Respiratory, Biomedical, and Dialysis Rental SolutionsWHITMORE LAKE, Mich.–(BUSINESS WIRE)–VGM and Trace Medical have executed an exclusive program agreement that expands VGM members’ access to Trace… Read more »
SOLVE FSHD Announces Recent Grant Awards to Accelerate Treatments for Facioscapulohumeral Muscular DystrophyVANCOUVER, British Columbia–(BUSINESS WIRE)–SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), today announced… Read more »
Haleon Appoints Richard Manso as US Chief Marketing Officer to Advance Data-driven, Consumer-centric Marketing in Delivering Better Everyday HealthWARREN, N.J.–(BUSINESS WIRE)–Today Haleon (NYSE: HLN), the consumer company that is solely focused on better everyday health, announced the appointment… Read more »
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination CapabilitiesPHILADELPHIA–(BUSINESS WIRE)–PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic… Read more »
Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan AfricaSAN DIEGO–(BUSINESS WIRE)—- $EVFM #BV–Women’s health innovator Evofem Biosciences, Inc. (OTCID: EVFM) (Evofem or the Company) today announced that it… Read more »
Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormackMINNEAPOLIS & SAN FRANCISCO–(BUSINESS WIRE)–Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of… Read more »
Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta VirusFOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in… Read more »
Boston Cell Standards Enters Final Phase of FDA MDDT Program to Qualify First-in-Industry Platform to Standardize Cancer Diagnostic AssaysBOSTON–(BUSINESS WIRE)– #cancerdiagnostics–Boston Cell Standards, Inc. (BCS), a private company bringing modern Quality tools and practices to Clinical Immunohistochemistry (IHC)… Read more »
Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to AstorgWALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed… Read more »
Samsung Bioepis Releases Second Quarter 2026 US Biosimilar Market ReportINCHEON, Korea–(BUSINESS WIRE)– #ASP–Samsung Bioepis Co., Ltd. released its Second Quarter 2026 Biosimilar Market Report. Read more »
Alpha Cognition Inc. to Participate in Three Upcoming Investor ConferencesVANCOUVER, British Columbia & GRAPEVINE, Texas–(BUSINESS WIRE)–Alpha Cognition, Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company… Read more »
Infinimmune Appoints Anthony Slavin, Ph.D., as Senior Vice President of Portfolio StrategyALAMEDA, Calif.–(BUSINESS WIRE)– #AI–Infinimmune Appoints Anthony Slavin, Ph.D., as Senior Vice President of Portfolio Strategy Read more »
SquareMind Raises $18 Million to Redefine Skin Exams With Robotics and AIPARIS–(BUSINESS WIRE)– #AI–SquareMind raises $18 million to redefine skin exams with the Swan robotic skin imaging platform. Read more »
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of DirectorsBOSTON–(BUSINESS WIRE)–PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors Read more »
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair LossNEW HAVEN, Conn.–(BUSINESS WIRE)–Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair… Read more »- GE HealthCare management to present at upcoming investor conferencesCHICAGO–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor… Read more »
Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of DirectorsBOSTON–(BUSINESS WIRE)–Seaport Therapeutics adds Intra-Cellular Therapies founder and CEO, Dr. Sharon Mates, to its Board of Directors Read more »
vVARDIS Announces Investment from Apollo —Achieves Unicorn StatusZUG, Switzerland–(BUSINESS WIRE)–vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority… Read more »- SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosusWILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca’s SAPHNELO® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector, the SAPHNELO Pen,… Read more »
Motif Neurotech Receives FDA Approval to Begin First Clinical Trial of its Therapeutic BCI for Treatment-Resistant DepressionHOUSTON–(BUSINESS WIRE)–Motif Neurotech announced that the FDA has approved an Investigational Device Exemption for their RESONATE Early Feasibility Study. Read more »
PlaqueTec Closes $5 Million FinancingCAMBRIDGE, England–(BUSINESS WIRE)–PlaqueTec, a medtech company pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease (CVD), today announced… Read more »
Sun Pharma signs Definitive Agreement to Acquire OrganonMUMBAI, India & JERSEY CITY, N.J.–(BUSINESS WIRE)–Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together… Read more »
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair LossNEW HAVEN, Conn.–(BUSINESS WIRE)–Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair… Read more »
Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation SystemLAGUNA HILLS, Calif.–(BUSINESS WIRE)—- $ADGM #Arrhythmia–Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter… Read more »
Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA… Read more »